Adelene Q Perkins - Net Worth and Insider Trading
Adelene Q Perkins Net Worth
The estimated net worth of Adelene Q Perkins is at least $119 dollars as of 2024-04-23. Adelene Q Perkins is the Director of Infinity Pharmaceuticals Inc and owns about 1,191,738 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $119. Details can be seen in Adelene Q Perkins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Adelene Q Perkins has not made any transactions after 2023-09-12 and currently still holds the listed stock(s).
Transaction Summary of Adelene Q Perkins
Adelene Q Perkins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adelene Q Perkins owns 2 companies in total, including Infinity Pharmaceuticals Inc () , and Bruker Corp () .
Click here to see the complete history of Adelene Q Perkins’s form 4 insider trades.
Insider Ownership Summary of Adelene Q Perkins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Infinity Pharmaceuticals Inc | 2023-09-12 | director & President & CEO | |
| Bruker Corp | 2017-05-22 | director |
Adelene Q Perkins Latest Holdings Summary
Adelene Q Perkins currently owns a total of 1 stock. Adelene Q Perkins owns 1,191,738 shares of Infinity Pharmaceuticals Inc (INFIQ) as of September 12, 2023, with a value of $119.
Latest Holdings of Adelene Q Perkins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INFIQ | Infinity Pharmaceuticals Inc | 2023-09-12 | 1,191,738 | 0.00 | 119 |
Holding Weightings of Adelene Q Perkins
Adelene Q Perkins Form 4 Trading Tracker
According to the SEC Form 4 filings, Adelene Q Perkins has made a total of 1 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 410,196 shares on September 12, 2023, which brought Adelene Q Perkins around $28,714.
Insider Trading History of Adelene Q Perkins
- 1
Adelene Q Perkins Trading Performance
GuruFocus tracks the stock performance after each of Adelene Q Perkins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adelene Q Perkins is 6.24%. GuruFocus also compares Adelene Q Perkins's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adelene Q Perkins within 3 months outperforms 6 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adelene Q Perkins's insider trading performs compared to the benchmark.
Performance of Adelene Q Perkins
Average Return
-4.3%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.74 | 6.24 | 0.55 | -4.3 | 11.3 | 3.27 |
| Relative Return to S&P 500(%) | 2.79 | 8.23 | -0.8 | -2.83 | 15.3 | 1.71 |
Adelene Q Perkins Ownership Network
Ownership Network List of Adelene Q Perkins
Ownership Network Relation of Adelene Q Perkins
Adelene Q Perkins Owned Company Details
What does Infinity Pharmaceuticals Inc do?
Who are the key executives at Infinity Pharmaceuticals Inc?
Adelene Q Perkins is the director & President & CEO of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include Chief Scientific Officer Stephane Peluso , Chief Medical Officer Robert Jr. Ilaria , and other: See Explanation of Responses Biotechnology Value Fund L P .
Infinity Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, Adelene Q Perkins made 1 insider transaction in Infinity Pharmaceuticals Inc () with a net sale of 410,196.
In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.
Infinity Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Infinity Pharmaceuticals Inc Insider Transactions
Adelene Q Perkins Mailing Address
Above is the net worth, insider trading, and ownership report for Adelene Q Perkins. You might contact Adelene Q Perkins via mailing address: C/o Infinity Pharmaceuticals, Inc., 780 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
